NCT05928234

Brief Summary

The goal of this observational study is to compare patients with pulmonary atresia with intact ventricular septum (PA-IVS) with univentricular circulation to patients with the same heart defect but that has a biventricular circulation in regards to mortality, quality of life, comorbidity, cardiac function, and work capacity. The main questions the study aims to answer are: • Do mortality, quality of life, comorbidity, cardiac function, and work capacity differ between patients with PA-IVS who have univentricular and biventricular circulation? Participants will be asked to answer a Quality of Life questionnaire. The investigators will also inquire with a sample size of the research subjects (based on place of residence) about their participation in a series of examinations (ergo-spirometry to assess work capacity, transthoracic echocardiogram, magnetic resonance of the heart and blood sampling to assess cardiac function and cardiac health).

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
140

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jul 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 4, 2023

Completed
29 days until next milestone

First Posted

Study publicly available on registry

July 3, 2023

Completed
1 year until next milestone

Study Start

First participant enrolled

July 15, 2024

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2026

Completed
Last Updated

March 30, 2025

Status Verified

March 1, 2025

Enrollment Period

1.4 years

First QC Date

June 4, 2023

Last Update Submit

March 25, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Difference in comorbidity between the two groups

    Difference in myocardial infarction, heart failure, arrhythmia, stroke, malignancy, autoimmune diseases, infections, atopy, certain liver diseases, and protein-losing enteropathy between the two groups

    September 2024

Secondary Outcomes (5)

  • Difference in quality of life between the two groups

    September 2024

  • Difference in physical capacity between the two groups

    September 2024

  • Difference in cardiac capacity between the two groups

    September 2024

  • Difference in general health, linked to cardiac health, between the two groups

    September 2024

  • Difference in mortality between the groups

    September 2024

Study Arms (2)

Biventricular circulation

Research subjects with PA-IVS who have biventricular circulation

Univentricular circulation

Research subjects with PA-IVS who have univentricular circulation

Eligibility Criteria

Age15 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study population consists of all individuals with PA-IVS who have been registered in Swedcon (a national register for patients with congenital heart defects) or in the National Patient Register and Cause of Death Register since 1980 and meet other inclusion criteria, including age.

You may qualify if:

  • Individuals born with pulmonary atresia with intact ventricular septum (PA-IVS) who are 15 years or older at the start of the study.
  • Regarding the mortality variable, research subjects who have died after the age of 15 years old will be included.

You may not qualify if:

  • Individuals born with pulmonary atresia with intact ventricular septum who are younger than 15 years old at the start of the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Pediatric Heart Center, Queen Silvia's Children's hospital

Gothenburg, 416 85, Sweden

RECRUITING

MeSH Terms

Conditions

Pulmonary Atresia with Intact Ventricular Septum

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD

Study Record Dates

First Submitted

June 4, 2023

First Posted

July 3, 2023

Study Start

July 15, 2024

Primary Completion

December 1, 2025

Study Completion

January 1, 2026

Last Updated

March 30, 2025

Record last verified: 2025-03

Locations